GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $143.66 $159.34 Thursday, 18th Apr 2024 ALNY stock ended at $145.16. This is 0.110% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 1.35% from a day low at $144.50 to a day high of $146.45.
90 days $143.52 $191.72
52 weeks $143.52 $218.88

Historical Alnylam Pharmaceuticals prices

Date Open High Low Close Volume
2023-08-08 $184.54 $186.90 $182.72 $184.84 487 244
2023-08-07 $185.61 $186.03 $182.77 $184.29 427 528
2023-08-04 $189.31 $189.31 $184.08 $185.58 560 539
2023-08-03 $182.13 $192.29 $180.02 $190.10 623 552
2023-08-02 $186.80 $187.50 $184.16 $187.01 618 142
2023-08-01 $193.40 $194.50 $187.47 $189.05 488 446
2023-07-31 $199.10 $200.17 $194.54 $195.40 394 701
2023-07-28 $196.59 $200.00 $195.00 $199.29 330 719
2023-07-27 $196.18 $196.54 $192.62 $194.87 631 578
2023-07-26 $193.42 $195.24 $190.05 $194.94 447 915
2023-07-25 $192.06 $195.13 $190.76 $193.46 685 827
2023-07-24 $201.19 $202.46 $190.88 $192.32 757 185
2023-07-21 $201.89 $202.36 $199.36 $200.07 296 919
2023-07-20 $204.33 $206.57 $200.00 $201.44 440 405
2023-07-19 $209.97 $210.56 $205.30 $205.32 412 762
2023-07-18 $202.77 $210.76 $200.13 $208.42 599 693
2023-07-17 $208.00 $218.88 $201.86 $202.83 1 234 048
2023-07-14 $203.54 $203.88 $196.90 $197.10 497 845
2023-07-13 $203.29 $205.37 $201.19 $203.88 456 715
2023-07-12 $204.09 $207.40 $201.77 $201.90 489 811
2023-07-11 $199.95 $202.71 $197.03 $202.15 500 849
2023-07-10 $192.60 $200.99 $192.60 $199.81 578 935
2023-07-07 $193.43 $195.98 $192.06 $192.68 284 024
2023-07-06 $190.37 $194.94 $190.08 $194.39 407 548
2023-07-05 $190.00 $194.40 $189.06 $192.57 328 916
Click to get the best stock tips daily for free!

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection f... ALNY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT